Science Signaling Podcast
Summary: Periodic audiocasts from Science Signaling, the leading journal of regulatory biology and cell signaling in physiology and disease
- Visit Website
- RSS
- Artist: Science Signaling
- Copyright: © 2017 American Association for the Advancement of Science
Podcasts:
Research from Erik Danen and colleagues suggests that, although therapies that interfere with cell adhesion signaling may slow the growth of some types of breast cancer, they may promote metastasis.
John He and Ravi Iyengar talk about their use of proteomic analysis and computational methods to identify potential targets for reversing kidney damage.
Yuichi Oike discusses his research on how the tumor microenvironment promotes expression of a gene that increases the likelihood of osteosarcoma metastasis.
Moses Chao and Eric Klann discuss how the antipsychotic drug haloperidol changes neuronal morphology.
Michaela Gack discusses how the deubiquitinase USP15 promotes interferon production to prolong the antiviral response.
Judith Davie discusses the mechanism by which too much of the inflammatory cytokine interferon-γ inhibits muscle repair.
Taku Kambayashi and Gary Koretzky discuss the different activities of the α and ζ isoforms of diacylglycerol kinase in T cell development.
Stanton Gelvin explains how cytokinins produced by bacteria promote infection by repressing a transcription factor in host plants.
Steve Rogers and Mark Peifer identify the G protein–coupled receptor Mist as the receptor for Fog, a secreted factor that drives gastrulation in fruit fly embryos.
Penelope Morel and James Faeder discuss their finding that the duration of T cell receptor signaling determines the fate of regulatory versus helper T cells.
Walter Koch explains how S-nitrosothiols protect heart cells from ischemia-induced cell death.
Ariel Feldstein discusses the identification of microparticles released by fat-laden hepatocytes that stimulate angiogenesis and contribute to the progression of fatty liver disease.
Carlos Gorbea discusses how a subset of proteasomes attenuates TLR3-mediated antiviral signaling.
Martin Miller and Chris Sander discuss combining a drug screen and network modeling to identify a potential combination therapy for lipsarcoma.
Peter Parker, Mark Linch, and Neil McDonald discuss a motif in an atypical protein kinase that mediates interactions with cell polarity substrates and is mutated in some cancers.